Iwona CICHA studied Biology at the Jagiellonian University, Cracow, Poland. After obtaining her PhD in medical sciences at the Ehime Medical School, Ehime University, Japan, she moved to University of Erlangen-Nürnberg in Germany. She was a postdoctoral fellow in the Department of Nephrology, before joining the Department of Cardiology, where she obtained her habilitation in Experimental Medicine in 2012. She has an extensive research experience in the field of atherosclerosis, with focus on the role of inflammation and blood flow dynamics in plaque development and destabilization. Since July 2013, she has been leading the Cardiovascular Nanomedicine Unit at the Section of Experimental Oncology and Nanomedicine (SEON), University Hospital Erlangen, and was nominated extraordinary professor in 2018.
Her studies focus on the application of nanomedical strategies for the diagnosis and treatment of cardiovascular diseases. She participated in 10 national projects as a PI, and was a coordinator of an international project funded by the German Ministry of Education and Research. Further, she was a PI in a large-scale EU-funded project “NanoAthero”, and is currently involved in a new ERA-Net project addressing cardiovascular nanocarriers. Her activities resulted in 117 peer-reviewed publications (H-index 36, 3745 citations, source: Scopus).
If needed: https://orcid.org/0000-0002-7399-5307
